Stock listing

Lang & Schwarz:520394 BRAIN Biotech AG Aktie

German listing (Lang & Schwarz) of BRAIN Biotech AG · home listing Xetra:BNN

Follow BRAIN Biotech AG into a list and get an email when it puts out news.

Home listing price · XETR:BNN

€2.82 EUR +0.04 (+1.4%)

Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, XETR:BNN

Past year +30.0% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
€2.47 – €2.82 EUROct 30, 2026
Volume
5,081 sharesOct 30, 2026
Market cap
€61.61M EURAt the close on Oct 30, 2026 · price × 21.85M shares outstanding
52-week range
€2.13 – €3.74 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
€15,762 EURMedian day 3,107 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
BRAIN Biotech AG logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Xetra:BNN · Home€2.82 EUR+0.04 (+1.4%)5,081€2.68€2.82€2.47€2.78Close on Oct 30, 2026
LSE:0RFI€2.71 EUR+0.03 (+1.1%)201€2.66€2.71€2.66€2.68Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · XETR:BNN · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.82+0.04+1.4%€2.68€2.82€2.475,081
€2.78+0.22+8.6%€2.61€2.86€2.6043,115
€2.56-0.20-7.2%€2.66€2.71€2.517,661
€2.760.000.0%€2.72€2.79€2.7240
€2.76+0.03+1.1%€2.60€2.78€2.604,399
€2.73-0.13-4.5%€2.86€2.86€2.731,026
€2.86+0.05+1.8%€2.80€2.87€2.771,682
€2.81+0.05+1.8%€2.76€2.86€2.68999
€2.76-0.10-3.5%€2.77€2.84€2.683,107
€2.86+0.19+7.1%€2.67€2.87€2.676,026
€2.67+0.01+0.4%€2.71€2.84€2.671,258
€2.66-0.07-2.6%€2.66€2.76€2.609,164
€2.73+0.03+1.1%€2.70€2.82€2.68607
€2.70+0.04+1.5%€2.77€2.79€2.665,975
€2.66-0.12-4.3%€2.81€2.87€2.654,260
€2.78+0.03+1.1%€2.75€2.88€2.726,354
€2.75-0.01-0.4%€2.82€2.88€2.754,653
€2.76-0.13-4.5%€2.89€2.89€2.767,587
€2.890.000.0%€2.89€2.89€2.765,706
€2.890.000.0%€2.78€2.89€2.784,280
€2.89+0.04+1.4%€2.80€2.89€2.765,076
€2.850.000.0%€2.85€2.85€2.673,829
€2.850.000.0%€2.80€2.85€2.804,275
€2.85+0.06+2.2%€2.85€2.85€2.732,730
€2.790.000.0%€2.72€2.85€2.725,993
€2.79-0.02-0.7%€2.89€2.89€2.724,396
€2.810.000.0%€2.81€2.89€2.754,925
€2.81-0.09-3.1%€2.81€2.90€2.7416,917
€2.90+0.10+3.6%€2.80€2.90€2.80459
€2.80+0.02+0.7%€2.72€2.80€2.72319
€2.78-0.02-0.7%€2.81€2.81€2.73547
€2.80-0.11-3.8%€2.85€2.85€2.753,188
€2.91+0.19+7.0%€2.90€2.91€2.8513
€2.72-0.06-2.2%€3.05€3.05€2.721,752
€2.78-0.01-0.4%€2.79€2.85€2.782,048
€2.79-0.07-2.4%€2.86€2.86€2.7995
€2.86-0.13-4.3%€2.96€3.05€2.738,377
€2.99+0.20+7.2%€2.81€2.99€2.7826,406
€2.79+0.18+6.9%€2.66€2.98€2.5659,896
€2.61+0.04+1.6%€2.81€2.81€2.619,732
€2.57-0.10-3.7%€2.60€2.60€2.571,028
€2.67+0.01+0.4%€2.65€2.77€2.652,546
€2.66-0.05-1.8%€2.65€2.67€2.651,252
€2.71+0.06+2.3%€2.79€2.79€2.715,680
€2.65-0.06-2.2%€2.75€2.75€2.652,799
€2.71-0.04-1.5%€2.72€2.72€2.701,650
€2.75-0.05-1.8%€2.73€2.83€2.678,167
€2.80+0.15+5.7%€2.65€2.80€2.654,646
€2.65-0.15-5.4%€2.22€2.79€2.227,707
€2.80+0.15+5.7%€2.70€2.84€2.65582
€2.65-0.18-6.4%€2.78€2.78€2.6518,513
€2.83-0.01-0.4%€3.05€3.05€2.78371
€2.84-0.03-1.0%€2.89€2.89€2.841
€2.87-0.01-0.3%€2.87€2.87€2.87800
€2.88+0.05+1.8%€2.85€2.88€2.85852
€2.83+0.03+1.1%€2.80€2.83€2.76500
€2.800.000.0%€2.76€2.80€2.76182
€2.80-0.01-0.4%€2.80€2.80€2.80158
€2.81-0.02-0.7%€2.78€2.85€2.761,109
€2.83+0.05+1.8%€2.78€2.88€2.78456
€2.78-0.05-1.8%€3.00€3.00€2.781,008
€2.83-0.06-2.1%€2.78€2.89€2.78385
€2.89+0.06+2.1%€3.05€3.05€2.89599
€2.83-0.07-2.4%€2.90€2.90€2.78999
€2.90-0.01-0.3%€2.95€3.04€2.8016,696
€2.91+0.15+5.4%€2.76€2.91€2.7610,321
€2.76+0.01+0.4%€2.82€2.82€2.765,720
Ticker
Lang & Schwarz:520394
Asset type
Stock
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma

Sep 9, 2026

Closed €2.99 (+7.2%) on Sep 9, 2026

BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA

Aug 27, 2026

Closed €2.75 (-1.8%) on Aug 27, 2026

Dr. Sven K. Weber Succeeds Adriaan Moelker as CEO of BRAIN Biotech AG

Jul 29, 2026

Closed €2.75 (+1.1%) on Jul 29, 2026

BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH

Jul 13, 2026

Closed €2.92 (+3.5%) on Jul 13, 2026

BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance

May 28, 2026

Closed €2.97 (+2.1%) on May 28, 2026

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

Mar 23, 2026

Closed €2.40 (+3.0%) on Mar 23, 2026

Results of the 2026 Annual General Meeting for the 2024/25 Financial Year of BRAIN Biotech AG

Mar 11, 2026

Closed €2.69 (+5.1%) on Mar 12, 2026

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase® Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds

Feb 25, 2026

Closed €2.81 (+30.1%) on Feb 25, 2026

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control

Jan 14, 2026

Closed €2.44 (-9.6%) on Jan 14, 2026

BRAIN Biotech AG Appoints Johan Jansen-Storbacka as Executive Vice President of the BRAINBiocatalysts' Enzyme Products Business

Sep 3, 2025

All BRAIN Biotech AG news

Decks

BRAIN Biotech AG on 6ix

News releases
10 in the last 12 months · 14 in all · newest Sep 9, 2026 · oldest 2025
Decks
21 decks · latest September 2026

Where BRAIN Biotech AG is listed

ListingExchangeCountryCurrency
Xetra:BNN · Home listingXetraGermanyEUR
Tradegate:BNNTradegateGermanyEUR
gettex:BNNgettexGermanyEUR
LSE:0RFILSEUnited KingdomEUR
LS Exchange:520394LS ExchangeGermanyEUR
Frankfurt:BNNFrankfurtGermanyEUR
Lang & Schwarz:520394 · This pageLang & SchwarzGermanyEUR
Aquis:BNNDAquisUnited KingdomEUR
BX Swiss:BNNBX SwissSwitzerlandCHF
Dusseldorf:BNNDusseldorfGermanyEUR
Munich:BNNMunichGermanyEUR
Hamburg:BNNHamburgGermanyEUR
Stuttgart:BNNStuttgartGermanyEUR
Aquis:BNNDAquisUnited KingdomEUR
BX Swiss:BNNEURBX SwissSwitzerlandEUR

Log in to ask 6ix AI your own questions about BRAIN Biotech AG.